Abstract:Objective To summarize the clinical features,treatment status and prognosis of severe community-acqnired pneumonia (CAP) caused by adenovirus in a single pediatric intensive care unit (PICU),and to explore the appropriate diagnosis and treatment strategies.Methods From August 2016 to January 2019,the clinical data of children with adenovirus pneumonia,including symptoms,organ function,laboratory features,rescue measures and results were analyzed retrospectively.Results A total of 531 cases with severe CAP were admitted in PICU,Shanghai Children's Hospital,Shanghai Jiaotong University.Among them,32 cases with adenovirus pneumonia accounted for 6.03％.The high incidence age was from 3 months to 2 years old (68.8％),and the average age was 18(12,37) months.High fever,respiratory distress and mental infirmity were the main symptoms.In acute stage,the pulmonary asymmetrical exudation lesion,partial exudation fusion and interstitial emphysema were observed by chest X rays.The main complications of extrapulmonary organ were cardiovascular disorder (63.1％),gastrointestinal disorder (50％),liver dysfunction (46.9％),coagulation dysfunction (31.3％) and nervous system dysfunction (26.1％).Respiratory support included high flow nasal oxygen therapy in 2 cases,mechanical ventilation in 30 cases,prone position ventilation in 12 cases,and continuous renal replacement therapy (CRRT) in 9 cases,extracorporeal membrane oxygenation (ECMO) therapy in 6 cases.There were 5 cases of death,and the hospital mortality was 15.6％.There were 4 cases survived by ECMO,and the discharge rate was 66.7％.Conclusion Adenovirus infection remains an important cause of CAP in PICU,and the mortality is high.Prone position ventilation,CRRT and ECMO may improve the survival rate of severe adenovirus pneumonia in children.

Antiviral Therapy of Adenovirus Pneumonia

Methods and Clinical Development of Adenovirus-Vectored Vaccines Against Mucosal Pathogens

Comparative Study on the Effect of Cidofovir Treatment for Severe Adenovirus Pneumonia

Antiviral Therapy for Severe Viral Pneumonia

Current antiviral agents against human adenoviruses associated with respiratory infections

Outcomes of Early Administration of Cidofovir in Non-Immunocompromised Patients with Severe Adenovirus Pneumonia

Pediatric adenovirus pneumonia: clinical practice and current treatment

Adenovirus: Epidemiology, Global Spread of Novel Types, and Approach to Treatment

Combined intravenous ribavirin and recombinant human interferon α1b aerosol inhalation for adenovirus pneumonia with plastic bronchitis in children: a case report and review of literature

Recent Advances in Novel Antiviral Therapies against Human Adenovirus

Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention

Research Progress on Early Identification of Severe Adenovirus Pneumonia in Children

[Research Progress in Human Adenovirus].

Characteristics and treatment of severe adenovirus pneumonia in pediatric intensive care unit

Progress in diagnosis and treatment of adenoviral pneumonia complicated with bronchiolitis obliterans in children

Clinical features and treatment of adenovirus infections

Treatment of a Case Presenting As Critical Adenoviral ARDS Using Cidofovir with Early Combinatorial Prone Ventilation and ECMO

The Chest High Resolution Computed Tomography (HRCT) Manifestation and Dynamic Changes in Adult Pa-Tients with Adenovirus Type 7 Pneumonia

Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues As Potent Human Adenovirus Inhibitors.

Difficulties in Diagnosis and Treatment of Pediatric Severe Adenovirus Pneumonia